Dexcom (DXCM) Non-Current Deffered Revenue (2011 - 2012)
Dexcom's (DXCM) quarterly Non-Current Deffered Revenue came in at $600000.0 in Q4 2012, up 100.0% year-over-year from $300000.0 in Q1 2012, and up 5.45% quarter-over-quarter from $569000.0 in Q3 2012.
Powered by 
Analysis
Dexcom (DXCM) Non-Current Deffered Revenue (2011 - 2012) Analysis & Trends
Dexcom (DXCM) has reported Non-Current Deffered Revenue for 2 consecutive years, with $600000.0 the latest figure, recorded in Q4 2012.
- On a quarterly basis, Non-Current Deffered Revenue rose 100.0% year-over-year to $600000.0 in Q4 2012; TTM through Dec 2012 was $600000.0, a 100.0% increase from a year earlier, with the FY2012 full-year figure at $600000.0, up 100.0% from the prior year.
- Non-Current Deffered Revenue was $600000.0 for Q4 2012 at Dexcom, up from $569000.0 in the prior quarter.
- Over five years, Non-Current Deffered Revenue peaked at $834000.0 in Q1 2012 and troughed at $300000.0 in Q4 2011.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | - |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | - |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | - |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | - |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | - |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | - |
| 10 | Zimmer Biomet Holdings | 18.00 Bn | 17.59 Bn | 1.54 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2012 | 600,000.00 |
| Sep 30, 2012 | 569,000.00 |
| Jun 30, 2012 | 702,000.00 |
| Mar 31, 2012 | 834,000.00 |
| Dec 31, 2011 | 300,000.00 |